Julphar
UAE - Ras Al KhaimahBiotechnology
Focus: Julphar is a mid-sized biopharmaceutical company headquartered in Ras Al Khaimah, UAE, with 1,001-5,000 employees focused on small molecules and biologics in metabolic disease. Founded in 1980, the company operates as a publicly traded entity on the Abu Dhabi Securities Exchange.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Employees
1001-5000
Open Jobs
0
About Julphar
AI assessmentNot HiringNo open roles listed right now. Follow Julphar to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Julphar Insulin N
Diabetes MellitusClinical Trials (1)
NCT02634528Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal
Phase 1Help build intelligence for Julphar
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.